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Heme biosynthesis pathway is conserved in yeast and 
humans and hem12 yeast mutants mimic porphyria cu-
tanea tarda (PCT), a hereditary human disease caused 
by mutations in the UROD gene. Even though mutations 
in other genes also affect UROD activity and predispose 
to sporadic PCT, the regulation of UROD is unknown. 
Here, we used yeast as a model to study regulation 
of Hem12 by ubiquitination and involvement of Rsp5 
ubiquitin ligase in this process. We found that Hem12 
is monoubiquitinated in vivo by Rsp5. Hem12 contains 
three conserved lysine residues located on the protein 
surface that can potentially be ubiquitinated and lysine 
K8 is close to the 36-LPEY-39 (PY) motif which binds WW 
domains of the Rsp5 ligase. The hem12-K8A mutation 
results in a defect in cell growth on a glycerol medium 
at 38oC but it does not affect the level of Hem12. The 
hem12-L36A,P37A mutations which destroy the PY motif 
result in a more profound growth defect on both, glycer-
ol and glucose-containing media. However, after several 
passages on the glucose medium, the hem12-L36A,P37A 
cells adapt to the growth medium owing to higher ex-
pression of hem12-L36A,P37A gene and higher stabil-
ity of the mutant Hem12-L36A,P37A protein. The Hem12 
protein is downregulated upon heat stress in a Rsp5-
independent way. Thus, Rsp5-dependent Hem12 mon-
oubiquitination is important for its functioning, but not 
required for its degradation. Since Rsp5 has homologs 
among the Nedd4 family of ubiquitin ligases in humans, 
a similar regulation by ubiquitination might be also im-
portant for functioning of the human UROD.
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INTRODUCTION
Rsp5 is a unique yeast member of the Nedd4 fam-
ily of ubiquitin ligases which have a common C2-WW-
HECT modular structure with the lipid-binding domain 
C2, protein-binding domains WW and catalytic HECT 
domain (Kaliszewski & Zoladek, 2008). The Rsp5 ligase 
monoubiquitinates and polyubiquitinates substrates with 
K63-linked ubiquitin chains in vivo and in vitro (Kee et al., 
2006). Some Rsp5 substrates are then transported via en-
docytosis to the vacuole for degradation (Lauwers et al., 
2010), others are proteolytically processed (Hoppe et al., 
2000) or have reduced activity (Novoselova et al., 2013). 
Rsp5 ubiquitinates a transcriptional activator, Spt23, 
thereby promoting its release from the endoplasmic re-
ticulum, also affecting its nuclear transport and transcrip-
tional activation of the OLE1 gene encoding a desaturase 
of fatty acids. This is an essential function since rsp5∆ 
strain cannot grow unless cells bear a plasmid encod-
ing a constitutively active variant Spt231-689 (Hoppe et al., 
2000). Rsp5 is also involved in proteasomal degradation 
of Rpb1, the largest subunit of the RNA polymerase II 
(Harreman et al., 2009). This protein is ubiquitinated in 
a two-step mechanism in which Rsp5 first adds mono-
ubiquitin and then a second ubiquitin ligase produces a 
K48-linked polyubiquitin chain, which triggers proteaso-
mal proteolysis (Harreman et al., 2009). The rsp5 mutants 
are hypersensitive to various toxic compounds, including 
hydrogen peroxide which causes oxidative stress (Hoshi-
kawa et al., 2003).
One of the proteins which binds to and is ubiquitinat-
ed by Rsp5 in vitro is Hem12 (Hesselberth et al., 2006; 
Gupta et al., 2007), a cytoplasmic uroporphyrinogen III 
decarboxylase (UROD), the fifth enzyme in the heme 
biosynthesis pathway. The HEM12 gene is essential in 
yeast and hem12∆  cells do not grow unless the medium 
is supplemented with ergosterol and unsaturated fatty 
acids since Erg5 sterol desaturase and Ole1 fatty acid 
desaturase are hemoproteins. The hem12∆ mutant cells 
supplemented with those lipids are still respiratory-defi-
cient and do not utilize glycerol, since they lack mito-
chondrial cytochromes. The heme biosynthesis pathway 
is conserved in humans and mutations in the human 
UROD gene resulting in UROD dysfunction cause a he-
reditary disease, porphyria cutanea tarda (PCT) (Frank 
& Poblete-Gutierrez, 2010), in which accumulation of 
porphyrins, phototoxic heme precursors, results in liver 
and skin damage (Mendez et al., 2012). Some mutations 
in the UROD gene result in lower activity and instability 
of UROD. Mutations in other genes may affect UROD 
activity and predispose to sporadic PCT by unknown 
mechanisms (Garey et al., 1993). In yeast cells, point mu-
tations in the HEM12 gene also lead to the accumula-
tion of porphyrins (Zoladek et al., 1996) and the hem12 
mutants mimic PCT (Kurlandzka et al., 1988). Yeast 
strains with mutations in unknown genes that affect ex-
pression of HEM12 have also been isolated, resembling 
the situation in humans (Zoladek et al., 1995). Moreover, 
UROD was recently identified as a potential anticancer 
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target and UROD inhibitor combined effectively with ra-
diation and other anticancer drugs (Yip et al., 2014).
Heme, as the prosthetic group of numerous hemopro-
teins, is crucial in electron transport in the mitochondrial 
oxidative chain, in several metabolic pathways, and in 
the defense against reactive oxygen species (Heinemann 
et al., 2008). Heme is essential for life but in excess it 
can be toxic to cells, therefore a crucial aspect of heme 
biosynthesis is its regulation. In mammals, the activity of 
5-aminolevulinic acid (ALA) synthase, catalyzing the first 
step of heme biosynthesis pathway, is rate-limiting (Pan-
da et al., 2002). Recently, a negative feedback regulation 
of heme homeostasis has been identified with Rev-erba 
heme receptor interacting with the NCoR protein to re-
press its target genes in human cells (Wu et al., 2009). 
Yeast growth on glycerol medium results in a ~3-fold 
induction of heme biosynthesis compared with glucose-
grown cells (Diflumeri et al., 1993). In yeast cells, ALA 
synthesis is not rate-limiting since ALA is present in 
excess; instead the rate-limiting are other enzymes, in-
cluding Hem12 UROD (Hoffman et al., 2003). Hem12 
protein could potentially be regulated post-translationally 
since it has been found to interact with WW domains of 
the Rsp5 ubiquitn ligase (Hesselberth et al., 2006) and be 
ubiquitinated in vitro (Gupta et al., 2007). Here, we ana-
lyzed a possible regulatory mechanism, ubiquitination of 
Hem12 protein in vivo, its dependence on the Rsp5 ubiq-
uitin ligase, and significance for yeast physiology.
MATERIALS AND METHODS
Strains, media and growth conditions. The Saccha-
romyces cerevisiae strains used were MHY501 (Chen et al., 
1993), PC10 rsp5-1 isogenic to MHY501 (P. Cholbinski 
IBB PAS), rsp5∆ (Hoppe et al., 2000), BY4741 and its 
derivative Y23983 HEM12/hem12∆::kanMX4 (Euro-
scarf). The hem12∆ mutants bearing plasmids with hem12-
K8A or hem12-L36A,P37A allele were obtained by spor-
ulation and tetrad dissection of respective transformants 
of a HEM12/hem12∆ diploid strain.
Yeast were grown in YPD with 2% glucose, YPGly 
with 2% glycerol, SD or SC with 2% glucose (Sherman, 
2002). YPD+G418 was used to select strains resistant 
to kanamycin, and sporulation medium (Sherman, 2002) 
for spore production. To monitor the effect of elevated 
temperature on the level of wild type and mutant HA-
Hem12, the respective yeast cells were grown at 28oC 
in SC-leu medium, transferred to YPD to OD600 ~0.3, 
grown for two generations and shifted to 38oC for 2 
or 4 hours. For cycloheximide-chase analysis of Hem12 
degradation, yeast were grown in YPD medium to the 
logarithmic phase, and 0.5 ml aliquots were removed for 
immunoblotting at indicated times following the addition 
of 500 mg/ml cycloheximide (Sigma).
Plasmids and plasmid construction. Plasmid YEp-
HIS-UBI was used (Stawiecka-Mirota et al., 2007). Plasmid 
pBS-HA-HEM12 was constructed by transfer of NotI di-
gested DNA fragment containing 3HA tag into the NotI 
site which was introduced after ATG codon of HEM12 orf 
by PCR in vitro mutagenesis of pBS-HEM12 (Zoladek et al., 
1995). Then SacI-HindIII fragment containing HA-HEM12 
was transferred to SacI- and HindIII-digested pRS415 and 
pRS425 (Invitrogen) to obtain pRS415-HA-HEM12 and 
pRS425-HA-HEM12. Mutations in HEM12 were intro-
duced by PCR mutagenesis of pBS-HA-HEM12, respec-
tive fragments transferred to pRS415 and pRS425 and con-
firmed by sequencing. Also, the SacI-HindIII fragment of 
pBS-HEM12 was used to obtain pRS415-HEM12.
Purification of ubiquitinated proteins. Purification 
of His-tagged ubiquitinated protein was performed as 
described previously (Stawiecka-Mirota et al., 2007). To-
tal extracts, Ni-NTA-sepharose (Qiagen)-bound and un-
bound fractions were analyzed by Western blotting using 
anti-HA antibody.
Western blotting. Protein extracts were prepared and 
Western blotting was performed as described previous-
ly (Stawiecka-Mirota et al., 2007). Anti-Nedd4 WW do-
main recognizing Rsp5 (Millipore), anti-Pgk1 (Molecular 
Probes), monoclonal anti-HA (12CA5, Covance), mono-
clonal anti-Vma2 (Molecular Probes) primary antibodies 
and secondary horseradish peroxidase-conjugated anti-
bodies (DACO) were used and followed by enhanced 
chemiluminescence (Millipore). HA-Hem12 and Rsp5 
levels were quantified using Image Quant and normal-
ized to Vma2, Pgk1 or Ponceau Red stained proteins.
Real-time PCR. Real-time RT-PCR was performed 
using the LightCycler®480 System (Roche Laborato-
ries) with SYBR Green detection. The primers’ specific-
ity was verified by melting curve analysis. Sequences of 
primers used are available upon request. RT-PCRs were 
performed in triplicate. cDNA was synthesized from 5 
μg of total RNA using RevertAidTM H Minus M-MuLV 
Reverse Transcriptase kit (Fermentas). Average cycle 
thresholds were calculated and the Pfaffl method (Pfaffl, 
2001) was used to calculate relative HEM12 expression 
levels with respect to 5S rRNA.
Computational analysis. A protein multiple sequence 
alignment was obtained with the MAFT program (Katoh 
& Toh, 2008) using homologs identified with BLAST 
(Schaffer et al., 2001). Several homologs of S. cerevisiae 
Hem12 with solved crystal structures have been indicat-
ed by BLAST and HHpred (Soding et al., 2005) servers. 
The structure of human uroporphyrinogen decarboxylase 
(PDB entry 1URO; (Whitby et al., 1998)) was chosen 
as a template to construct a model of Hem12 protein. 
Structural models of wild type and mutant Hem12 were 
obtained using the Sybyl-x1.2 package (TRIPOS, Inc., 
USA). The model structures were subjected to energy 
minimization using AMBERFF99 force field as imple-
mented in Sybyl-x1.2.
RESULTS AND DISCUSSION
The Hem12 protein is monoubiquitinated by the Rsp5 
ligase in vivo
Since in vitro experiments had identified Hem12 as 
a substrate of Rsp5 (Gupta et al., 2007), we inquired if 
Rsp5 contributes to regulation of the heme biosynthe-
sis pathway via in vivo ubiquitination and regulation of 
Hem12. To answer this question we used a HA-tagged 
version of HEM12 expressed from a plasmid restoring 
viability of a hem12∆ strain on rich glucose medium at 
28oC (Fig. 1A). The wild type or the rsp5∆ strain, where 
a plasmid encoding Spt231-689 ensured viability (Hoppe 
et al., 2000), were transformed with single- or multicopy 
plasmids bearing HA-HEM12. Western blot analysis re-
vealed that the level of HA-Hem12 overexpressed from 
a multicopy plasmid was increased 13–16 fold (Fig. 1B). 
To test if Hem12 is ubiquitinated in vivo we used strains 
expressing HIS-UBI encoding His-ubiquitin (Stawiecka-
Mirota et al., 2007) and HA-HEM12 from the multicopy 
plasmid. His-ubiquitinated proteins were purified on 
Ni-sepharose beads and were analyzed by Western blot-
ting with anti-HA antibody. Results shown in Fig. 1C 
document that HA-Hem12 is monoubiquitinated in vivo. 
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When the Rsp5 ubiquitin ligase is absent, ubiquitina-
tion of Hem12 is abolished to nearly background levels, 
which may indicate that in the absence of Rsp5 another 
ligase partially takes over. An additional copy of RSP5 
giving rise to a 3.5-fold elevated level of Rsp5 essential-
ly did not increase the ubiquitination of Hem12. Thus, 
Rsp5 ubiquitinates Hem12 in vivo and some factors con-
trol the level of this ubiquitination tightly. The presence 
of an additional copy or deletion of RSP5 essentially did 
not affect the steady state level of the Hem12 protein 
(Fig. 1B, C). Unlike polyubiquitination, monoubiquitina-
tion does not direct proteins to proteasomal degradation 
since proteasomes only recognize proteins tagged with 
K48-linked polyubiquitin chains containing more than 
four ubiquitins. Instead, monoubiquitination recruits pro-
teins containing ubiquitin-binding domains (UBDs) and 
provides a signaling mechanism that regulates several 
cellular pathways (Ikeda & Dikic, 2008). Thus, the Rsp5-
dependent monoubiquitination probably does not direct 
Hem12 for degradation but could affect its functioning 
through some other mechanism.
K8A substitution in Hem12 affects growth of cells on 
glycerol medium at an elevated temperature
Hem12 is highly conserved in evolution. UROD has 
a homodimeric structure with the active site clefts fac-
ing each other and all decarboxylation events occurring 
only in one active site (Martins et al., 2001; Bushnell et 
al., 2010). Assuming that the regulation of UROD by 
ubiquitination might be also conserved, we compared 34 
UROD amino acid sequences to find conserved lysine 
residues which could be potential ubiquitination sites. 
Alignment of three sequences is presented in Fig. 2A. 
We found that five lysines: K8, K99, K174, K242 and 
K260 of Hem12 are conserved. Computer modeling of 
the Hem12 structure (Fig. 2B) showed that two of them, 
K174 and K260, are located on the dimer interface but 
three others are potentially available for ubiquitination. 
Since K8 is very close to the PY motif 36-LPEY-39 
which binds the WW1 and WW3 domains of Rsp5 (Hes-
selberth et al., 2006) we assumed that this lysine is likely 
the ubiquitination site. Computer modeling indicated that 
substitution of K8 with alanine should not affect the 
protein structure (not shown). Therefore, the HA-hem12-
K8A mutant allele was constructed by in vitro mutagene-
sis and tested for complementation of hem12∆ inviability. 
A heterozygous HEM12/hem12∆ strain was transformed 
with a plasmid bearing the mutant allele, sporulated and 
tetrads were dissected. The hem12∆ [HA-hem12-K8A] 
spores were viable and their growth was comparable to 
that of wt [HA-hem12-K8A] and hem12∆ [HA-HEM12] 
strains on medium containing glucose or glycerol, a non-
fermentable carbon source, at 28oC (Figure 3A and not 
shown). However, the hem12∆ [HA-hem12-K8A] mutant 
strain grew significantly slower on the glycerol medium 
at 38oC when compared with wt [HA-hem12-K8A] and 
hem12∆ [HA-HEM12] (Fig. 3A and not shown). We 
observed a similar steady state level of HA-Hem12 and 
HA-Hem12-K8A proteins in cells grown at 28oC, and 
a similar 5-fold decrease of the steady state level after 
4 hours of incubation at 38oC (Fig. 3B). These results 
Figure 1. Hem12 protein is monoubiuqitinated in vivo and this ubiquitination depends on Rsp5. 
(A) HA-HEM12 complements lethality of hem12∆. Diploid HEM12/hem12∆::kanMX4 was transformed with pRS415-HA-HEM12 plasmid, tet-
rads were obtained and spore clones tested for growth on YPD and YPD+G418. (B) Additional copy of RSP5 or deletion of RSP5 does not 
affect the level of Hem12. Wild type strain (MHY501) was transformed with an empty vector, pRS415-HA-HEM12 or multicopy pRS425-
HA-HEM12 ([HA-HEM12]N) and with YCp33-RSP5 or empty vector for control. Strain rsp5∆ bearing plasmid expressing SPT231-689 was trans-
formed with pRS415-HA-HEM12 or pRS425-HA-HEM12. All of these strains also contained the YEp-HIS-UBI plasmid. Protein extracts were 
analyzed by Western blotting with anti-HA antibody. (C) Hem12 is ubiquitinated. Transformants expressing HIS-UBI and HA-HEM12 from 
multicopy plasmids as in B, were grown, protein extracts were prepared, and His-ubiquitinated proteins were purified using Ni-sepharose 
resins. Total extracts and Ni-bound fractions were analysed by Western blotting with anti-HA antibody. Rsp5 was detected by anti-Nedd4 
antibody and anti-Pgk1 was used to control for protein loading. HA-Hem12 and Rsp5 levels were quantified.
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indicate that Hem12 is subject to downregulation upon 
heat stress and suggest that the hem12-K8A mutation 
does not affect the stability of Hem12 but negatively af-
fects its activity or interaction with other proteins at the 
elevated temperature. Lysines other than K8 of Hem12 
could be ubiquitinated and direct the wild type and mu-
tant Hem12-K8A protein for degradation at an elevated 
temperature. In fact, Hem12-K8A mutant protein is still 
monoubiquitinated (not shown).
To investigate if Rsp5 is important for the degrada-
tion of Hem12 upon heat stress, the level of wild type 
Hem12 was monitored in wild type yeast and rsp5-1 mu-
tant with the L733S substitution in the catalytic HECT 
domain showing a temperature-sensitive growth defect 
(Wang et al., 2001). Yeast were grown at 28oC, shifted 
for 2 or 4 hours to 38oC, and Western blotting was per-
formed. The steady state level of Hem12 was lower in 
rsp5-1 than in wild type cells but this protein was simi-
larly degraded upon heat stress in both strains showing 
again that Rsp5 does not affect its degradation (Fig. 3C). 
This is in contrast to the recent finding that Rsp5 is the 
main ubiquitin ligase that targets cytosolic proteins fol-
lowing heat stress (Fang et al., 2014). Thus, another li-
gase must be involved in forming polyubiquitin chains 
that direct Hem12 for proteasomal degradation. Previous 
in vitro experiments have revealed that Hem12 may be 
also a substrate of the cytosolic ligase Ubr1 (Lu et al., 
2008) which functions in quality control of cytoplasmic 
proteins (Eisele & Wolf, 2008; Xia et al., 2008). It is pos-
sible that Rsp5 and Ubr1 function together in Hem12 
ubiquitination in vivo. Moreover, Ubr1 could be respon-
sible for the residual monoubiquitination of Hem12 ob-
served in the rsp5∆ strain.
Double mutation hem12-L36A,P37A destroying the 
PY motif in Hem12 prevents cell growth on glycerol 
medium
To eliminate Rsp5 binding and ubiquitination of 
Hem12, L36A and P37A mutations which make the PY 
motif not functional (Merhi & Andre, 2012) were intro-
duced into a plasmid carrying HA-HEM12. Computer 
modeling showed that these mutations should not affect 
the structure of the Hem12 catalytic center (not shown) 
and thus should not affect its catalytic activity. The het-
erozygous HEM12/hem12∆ strain was transformed with 
the above plasmid, sporulated and spore clones were 
isolated. The hem12∆ [HA-hem12-L36A,P37A] spores 
were viable but grew extremely slowly at 28oC on the 
glucose medium and not at all on the glycerol medium 
(Fig. 4A) suggesting that the mutant protein is barely ac-
tive. This phenotype is much stronger than phenotype 
of hem12-K8A mutant suggesting that another lysine 
could be ubiquitinated when K8 is absent. Interesting-
ly, after 2–3 passages on the glucose medium hem12∆ 
Figure 2. Five lysines are conserved in UROD. 
(A) Alignment of amino acid sequences of UROD from S. cerevisiae, Danio rerio and Homo sapiens. Evolutionarily conserved lysines are 
purple, LPEY/F motif is in green. (B) Model of S. cerevisiae Hem12 structure. The active enzyme is a homodimer, individual monomers are 
shown in light and dark blue. Amino acid residues forming the active site are marked in yellow. Conserved lysines K8, K99, K174, K242 
and K260 are in pink. Conserved LPEY motif which binds WW domains of Rsp5 is in green.
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Figure 3. Effect of hem12-K8A mutation on cell growth on glycerol medium and the level of mutant HA-Hem12 protein. 
(A) Complementation of hem12∆ by HA-hem12-K8A. HEM12/hem12∆::kanMX4 diploid was transformed with pRS415-HA-hem12-K8A, tet-
rads were obtained and growth of spore clones was compared. (B) The level of HA-Hem12 decreases at an elevated temperature but 
is not affected by hem12-K8A mutation. The hem12∆ [HEM12], hem12∆ [HA-HEM12] and hem12∆ [HA-hem12-K8A] strains were grown in 
YPGly at 28oC, shifted or not shifted to 38oC for 2 or 4 hours, extracts were analyzed by Western blotting using anti-HA and anti-Vma2 
antibodies. (C) The rsp5-1 mutation does not affect the degradation of Hem12 at an elevated temperature. Western blot using anti-HA 
antibody of wild type and rsp5-1 cells expressing HA-Hem12 from single copy plasmid. HA-Hem12 levels were quantified.
Figure 4. Effect of hem12-L36A,P37A mutation on cell growth and the level and stability of mutant Hem12 protein. 
(A) Complementation of hem12∆ by HA-hem12-L36A,P37A. HEM12/hem12∆::kanMX4 diploid was transformed with pRS415-HA-hem12-
L36A,P37A, tetrads were obtained and growth of spore clones was tested on YPD and YPGly at 28oC. (B) The level of HA-Hem12-
L36A,P37A protein in various strains. The hem12∆ [HEM12], hem12∆ [HA-HEM12] strains were grown in YPD to log phase. The hem12∆ 
[HA-hem12- L36A,P37A] strain was reinoculated three times into fresh YPD and then grown to log phase. Extracts were analyzed by West-
ern blotting using anti-HA and anti-Vma2 antibodies (left panel). The wt [HA-HEM12], wt [HA-hem12- L36A,P37A], rsp5∆ [HA-HEM12] and 
rsp5∆ [HA-hem12- L36A,P37A] strains were grown in SC medium, transferred to YPD and allowed to grow for two generations. Extracts 
were analyzed using anti-HA antibodies (right panel). One representative experiment of two is shown. (C) Cycloheximide chase analysis 
of wild type and mutant Hem12 levels in hem12∆ [HA-HEM12] and hem12∆ [HA-hem12- L36A,P37A] strains. HA-Hem12 turnover was mon-
itored by Western blotting using anti-HA and anti-Vma2 antibodies at indicated chase times after addition of cycloheximide to cultures 
grown in YPD medium. HA-Hem12 levels were quantified.
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[HA-hem12-L36A,P37A] spore clones achieved a nor-
mal rate of growth. Western blotting showed that the 
level of the mutant Hem12-L36A,P37A was greatly el-
evated in those strains, up to 6.5-fold over the wild type 
level (Fig. 4B, left panel). The glucose-adapted hem12∆ 
[HA-hem12-L36A,P37A] spore clones also grew on the 
glycerol medium (not shown). The level of HA-Hem12-
L36A,P37A in wild type and rsp5∆ strain transformed 
with a plasmid bearing HA-hem12-L36A,P37A gene 
was similar to that of the wild type HA-Hem12 pro-
tein (Fig. 4B, right panel). This shows that HA-Hem12-
L36A,P37A is present at increased levels only in the ab-
sence of wild type Hem12 protein and also that Rsp5 is 
not involved in its degradation.
The high steady state level of HA-Hem12-L36A,P37A 
protein in hem12∆ [HA-hem12-L36A,P37A] cells could 
result from an increased stability of the protein, from 
the induction of HA-hem12-L36A,P37A expression, or 
both. However, in our previous experiments (Fig. 1B) 
deletion of the RSP5 gene did not significantly affect 
the level of HA-Hem12, suggesting that the mutation 
of Hem12 preventing its modification by Rsp5 should 
not have caused its stabilization. To clarify that, Hem12 
stability was investigated. Cycloheximide was added 
to logarithmic phase cultures of wild type and hem12∆ 
[HA-hem12-L36A,P37A] spore clones to inhibit cytosolic 
protein synthesis and cell samples were taken at 30 or 
60-min intervals. Western blot analysis of cell extracts 
showed that in fresh spore clones the level of mutant 
HA-Hem12-L36A,P37A was lower compared with that 
of the wild type (Fig. 4C, left panel time 0). The low lev-
el of the mutant protein cannot be solely responsible for 
growth defect of hem12∆ [HA-hem12-L36A,P37A] spore 
clones since the Sm39 mutant showing a similar low lev-
el of wild type Hem12 grows well on glycerol medium 
(Zoladek et al., 1995). The wild type Hem12 protein was 
rather stable and was degraded in two phases, a faster 
one with a half-life below 50 min and a slower phase 
with a half-life above 200 min (Fig. 4C, right panel). 
This result indicates that two pools of Hem12 protein 
are present in wild type cells, one that is prone to deg-
radation and one protected from degradation, possibly 
by binding to other proteins. Degradation of the mutant 
HA-Hem12-L36A,P37A was slower than that of wild 
type Hem12, especially in the first phase. Thus, prevent-
ing the binding of Hem12 by Rsp5 resulted in Hem12 
stabilization. Considering that Rsp5 does not affect the 
degradation of Hem12 this effect is probably indirect 
and unrelated to Hem12 ubiquitination by Rsp5.
To learn if changes in expression of the HEM12 gene 
contribute to the observed high level of HA-Hem12-
L36A,P37A mutant protein, the HEM12 transcript was 
analyzed. RNA was isolated from wild type and hem12∆ 
[HA-hem12-L36A,P37A] spore clones propagated on glu-
cose medium for three days, and quantified by RT-PCR. 
The level of HA-hem12-L36A,P37A mRNA was 2.15 
fold higher than that of HEM12 mRNA. These results 
collectively show that the HA-hem12-L36A,P37A mutant 
does not initially grow on the glycerol medium possi-
bly because of low activity of the mutant HA-Hem12-
L36A,P37A protein but easily adapts to that medium by 
increasing the level of the mutant protein through in-
creased expression of the encoding gene and increased 
stability of the mutant HA-Hem12-L36A,P37A protein.
The obtained results led us to propose a model in 
which Hem12 is bound and mono-ubiquitinated by 
Rsp5, possibly at K8. The Rsp5-dependent ubiquitina-
tion does not direct Hem12 to degradation. The Rsp5 
binding and the monoubiquitination of Hem12 indepen-
dently help it to bind some unidentified protein which 
is required for efficient heme synthesis, cell survival and 
ability to grow on the glycerol medium.
Yeast Hem12 protein shows 50% identity and 67% 
similarity to the human UROD enzyme, which contains 
the LPEF motif. Therefore, human UROD could be also 
ubiquitinated and regulated by a human ubiquitin ligase 
of the Nedd4 family. Mutations affecting monoubiquit-
ination or promoting degradation of UROD could pos-
sibly be one of the reasons of PCT in humans for which 
no mutation in the UROD gene has been found. Further 
work will be required to confirm the postulated ubiqui-
tination of UROD and to establish its physiological role 
in humans.
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